IC2PerMed: Roadmap

News

Jun 30, 2023

Integrating China in the International Consortium for Personalized Medicine (IC2PerMed) project aims to support the European Union (EU)-China collaboration over the developments of personalized medicine research, innovations, and policies through the International Consortium for Personalized Medicine (ICPerMed) initiative, providing people with access to personalized, smart, and inclusive healthcare solutions in the near future.

Over the past 4 years, the IC2PerMed project has developed a roadmap that aims to promote consistent approaches to personalized medicine research, development, innovation, and policies between the People’s Republic of China and the EU.

The roadmap proposes, through the actions listed below, items to deepen and promote alignment and creation of a common ground for European and Chinese collaborations on personalized medicine.

Improving: Empowered and Responsible Citizens

  • Health Literacy
  • Research
  • Public Trust
  • Ethical Challenges

Promoting: Trained and Up-to-Date Healthcare Workforce

  • Education and Ethics
  • Collaborations
  • Policies

Fostering: Healthcare Systems’ Sustainability

  • Resources
  • Ethical, Legal, and Social Implications (ELSI) and Costs
  • Evaluation
  • Networks

Bringing: Innovation to Market

  • Cost Effectiveness
  • Needs Assessments
  • Principles and Guidelines
  • Perspectives

Adopting: Big Data and ICT Solutions

  • Data Exchange
  • Privacy, Security, and Trust
  • Standards

Fostering: Research funding

  • Patient Needs
  • Value Chain
  • Synergies

Translating: Basic Clinical Research and Beyond

  • Omics Sciences
  • Data and Standards
  • Collaborations

The roadmap was presented during the High-Level Symposium on Health Policy and Personalized Medicine for Cancer: Projecting Europe-China Collaboration in the Global Arena, organized by the WFPHA in Geneva, Switzerland, on May 26, 2023.

Read More